007 Upregulation of miR-941 in Peripheral CD14+ Monocytes Enhances Osteoclast Activation and Osteolysis in Patients With Psoriatic Arthritis: A Potential Diagnostic Biomarker and Treatment Target

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

MiR-146a-5p Expression in Peripheral CD14+ Monocytes From Patients With Psoriatic Arthritis Induces Osteoclast Activation, Bone Resorption, and Correlates With Clinical Response

Journal of Clinical Medicine
2019English

Peripheral Neuropathy in Patients With Psoriatic Arthritis

ScienceRise: Medical Science
2019English

CD16 (FcRγIII) as a Potential Marker of Osteoclast Precursors in Psoriatic Arthritis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Activation of Monocytes and Cytokine Production in Patients With Peripheral Atherosclerosis Obliterans

Journal of Inflammation
Clinical BiochemistryCell Biology
2011English

Clinical Experience of Cyclosporin Treatment in Patients With Psoriasis and Psoriatic Arthritis

Journal of Dermatology
DermatologyMedicine
2017English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

miR-941 as a Promising Biomarker for Acute Coronary Syndrome

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2017English

Anti-Mda5 Antibody as a Potential Diagnostic and Prognostic Biomarker in Patients With Dermatomyositis

Oncotarget
Oncology
2017English

Ultrasonography and Doppler in Patients With Psoriasis and Psoriatic Arthritis

European Journal of Dermatology
Dermatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy